Janux Therapeutics Stock Forecast for 2023 - 2025 - 2030
Updated on 05/02/2024
Janux Therapeutics Stock Forecast and Price Target
According to three esteemed experts, the average price target for Janux Therapeutics to reach this year is $53.00, with a potential downside of approximately -15.1%. This prediction is based on a high estimate of $100.00 and a low estimate of $25.00.
-15.10% Downside
Janux Therapeutics Fair Value Forecast for 2023 - 2025 - 2030
Janux Therapeutics's Price has seen growth In the last three years, going from $0.00 to $0.00 – a gain of 100.00% In the next year, analysts believe that Fair Value will reach $0.00 – an increase of 100.00%. For the next six years, the forecast is forFair Value to grow by 100.00%.
Janux Therapeutics Revenue Forecast for 2023 - 2025 - 2030
Janux Therapeutics's Revenue has seen growth In the last two years, going from $3.64M to $8.08M – a gain of 121.98% For the next year, 0 analysts project Janux Therapeutics's Revenue to drop by 14.87%, reaching $6.88M. By 2030, professionals believe that Janux Therapeutics's Revenue will decrease by 15.39%, reaching $6.84M – a concerning trend for the company.
.jpg)
Janux Therapeutics EBITDA Forecast for 2023 - 2025 - 2030
In the last three years, Janux Therapeutics's EBITDA has increased by 1370.39%, going from $-4.83M to $-71.02M. According to 0 major analysts, Janux Therapeutics's EBITDA will fall by 47.49% in the next year, reaching $-37.29M. Professionals believe that By 2030, Janux Therapeutics's EBITDA will fall to $-50.56M– a 28.81% decrease from its current value.
Janux Therapeutics EBIT Forecast for 2023 - 2025 - 2030
In the last three years, Janux Therapeutics's EBIT has grown, increasing from $-4.84M to $-72.98M – an increase of 1407.85%. In the next year, 0 analysts estimate that Janux Therapeutics's EBIT will decrease by 48.10%, reaching $-37.88M. According to professional forecasts, in 2030, Janux Therapeutics's EBIT will decrease by 29.29%, reaching $-51.60M.
Janux Therapeutics EPS Price Prediction Forecast for 2023 - 2025 - 2030
Janux Therapeutics's EPS has seen growth In the last three years, going from $-1.39 to $0.00 – a gain of 100.00% In the next year, analysts believe that EPS will reach $0.00 – an increase of 100.00%. For the next six years, the forecast is forEPS to grow by 100.00%.
.jpg)